Synthetic MR AB (LTS:0G79) 3-Year EBITDA Growth Rate : 56.60% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Synthetic MR AB 3-Year EBITDA Growth Rate?

Synthetic MR AB's EBITDA per Share for the three months ended in Dec. 2023 was kr0.23.

During the past 12 months, Synthetic MR AB's average EBITDA Per Share Growth Rate was 46.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 56.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Synthetic MR AB was 56.60% per year. The lowest was -126.50% per year. And the median was 0.75% per year.

Competitive Comparison of Synthetic MR AB's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, Synthetic MR AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthetic MR AB's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's 3-Year EBITDA Growth Rate falls into.

Synthetic MR AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Synthetic MR AB (LTS:0G79) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Synthetic MR AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthetic MR AB (LTS:0G79) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (LTS:0G79) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SYNT:Sweden

Address

Storgatan 11, Linkoping, SWE, SE-582 23

Website

https://www.syntheticmr.com

Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (LTS:0G79) Headlines

No Headlines